Package Leaflet: Information for the User
Setofilm 4 mg Oral Disintegrating Films EFG
Ondansetron
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the Package Leaflet
Setofilm contains a medicine called ondansetron. This belongs to a group of medicines called antiemetics.
Setofilm is used to prevent and treat nausea and vomiting caused by chemotherapy or radiotherapy. It can also be used to prevent and treat nausea and vomiting after an operation.
Do not take Setofilm
For more information, see the section "Other medicines and Setofilm".
Warnings and precautions
Consult your doctor, pharmacist, or nurse before taking Setofilm if:
If you need to have a blood or urine test, tell the person taking the test that you are taking Setofilm.
If you are not sure if any of the above applies to you, tell your doctor, pharmacist, or nurse before taking Setofilm.
Other medicines and Setofilm
Tell your doctor, pharmacist, or nurse if you are taking, have recently taken, or might take any other medicines. This includes medicines that you buy without a prescription and herbal medicines. This is because Setofilm can affect the way some medicines work and some medicines can affect the way Setofilm works.
In particular, tell your doctor, pharmacist, or nurse if you are taking:
If you are not sure if any of the above applies to you, talk to your doctor, pharmacist, or nurse before taking Setofilm.
Using Setofilm with food and drink
You can take Setofilm with or without food and drink.
Pregnancy, breastfeeding, and fertility
Pregnancy:
Setofilm should not be used during the first trimester of pregnancy. This is because Setofilm may slightly increase the risk of a baby being born with a cleft lip and/or palate (openings or gaps in the upper lip or the roof of the mouth).
If you are pregnant, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. If you are a woman of childbearing age, you are advised to use an effective method of contraception.
Breastfeeding:
You should not breastfeed while taking Setofilm, as Setofilm may pass into breast milk.
Fertility:
There is no information on the effects of ondansetron on human fertility.
Driving and using machines
Setofilm has little or no influence on the ability to drive and use machines.
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, check with your doctor or pharmacist.
Setofilm is taken by mouth only. It may be recommended for patients who may have difficulty swallowing tablets, such as children or elderly patients.
Treatment and prevention of nausea and vomiting in patients receiving chemotherapy or radiotherapy
Elderly patients:
Setofilm is well tolerated by these patients. These patients can take the same doses as other adults (see below).
Adults:
8 mg, 1-2 hours before chemotherapy or radiotherapy, followed by 8 mg every 12 hours for up to 5 days. Your doctor may recommend that the first dose is given by injection.
Children (from 6 months) and adolescents (under 18 years):
Your doctor will recommend the dose of ondansetron to be given. The individual dose will depend on the child's weight or body surface area.
Prevention and treatment of post-operative nausea and vomiting
Elderly patients:
Ondansetron is well tolerated by these patients. These patients can take the same doses as other adults (see below).
Adults:
Children over 4 years and adolescents:
Children weighing 40 kg or more can take 4 mg of Setofilm 1 hour before the operation, followed by a further dose of 4 mg 12 hours later.
Liver impairment:
Do not take more than 8 mg of ondansetron per day if you have moderate or severe liver problems.
If you take more Setofilm than you should
If you or your child take more Setofilm than you should, talk to a doctor or go to the nearest hospital immediately. Take the medicine with you.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, telephone: 91 562 04 20, indicating the medicine and the amount taken. Take the medicine packaging with you.
If you forget to take Setofilm
If you forget to take Setofilm and you feel unwell or vomit
If you forget to take a dose but do not feel unwell or vomit
.
If you stop taking Setofilm
If you feel unwell and stop taking Setofilm, tell your doctor or nurse as soon as possible.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Some side effects can be serious:
Stop taking Setofilm and contact your doctor or go to the nearest hospital immediately if you or your child experience any of the following symptoms:
Allergic reactions:
Signs of an allergic reaction can be:
Myocardial ischemia:
Signs include:
Other side effects include:
Very common side effects (affect more than 1 in 10 people)
Common side effects (affect less than 1 in 10 people)
Uncommon side effects (affect less than 1 in 100 people)
Rare side effects (affect less than 1 in 1,000 people)
Very rare side effects (affect less than 1 in 10,000 people)
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Vigilance System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Keep the sachet tightly closed to protect it from moisture.
Do not use this medicine after the expiry date which is stated on the packaging after EXP. The expiry date is the last day of the month shown.
Do not use Setofilm if you notice it is damaged.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Setofilm
The active substance is ondansetron. Each film contains 4 mg or 8 mg of ondansetron.
The other ingredients are: polyvinyl alcohol, Macrogol 1000, potassium acesulfame (E950), glycerol (E422), titanium dioxide (E171), rice starch, levomenthol, and polysorbate 80 (E433).
Appearance and packaging of the product
Setofilm 4 mg are white, rectangular oral disintegrating films (3 cm2 in size).
Setofilm 4 mg oral disintegrating films are packaged in sachets. Each carton contains 6, 10, or 50 sachets.
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder:
Norgine de España, S.L.U.
Paseo de la Castellana, 91, 2ª Planta
28046 Madrid
SPAIN
Manufacturer(s):
LTS Lohmann Therapie-Systeme AG
Lohmannstrasse 2
D-56626 Andernach
GERMANY
This medicine is authorised in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:Setofilm: France, United Kingdom (Northern Ireland), Belgium, Spain, Italy.
Date of last revision of this leaflet:April 2023
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.